Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1508 ARTÍCULOS , VIENDO DEL 1156 AL 1170

The genetic landscape of Alzheimer disease: clinical implications and perspectives

Van Cauwenberghe C, Van Broeckhoven C, Sleegers K.

Genet Med. 2016 May;18(5):421-30. doi: 10.1038/gim.2015.117. Epub 2015 Aug 27.

Multisite assessment of NIA-AA guidelines for the neuropathologic evaluation of Alzheimer's disease

Montine TJ, Monsell SE, Beach TG, Bigio EH, Bu Y, Cairns NJ, Frosch M, Henriksen J, Kofler J, Kukull WA, Lee EB, Nelson PT, Schantz AM, Schneider JA, Sonnen JA, Trojanowski JQ, Vinters HV, Zhou XH, Hyman BT.

Alzheimers Dement. 2016 Feb;12(2):164-169. doi: 10.1016/j.jalz.2015.07.492. Epub 2015 Aug 29.

Hybrids: a new paradigm to treat Alzheimer's disease

Singh M, Kaur M, Chadha N, Silakari O.

Mol Divers. 2016 Feb;20(1):271-97. doi: 10.1007/s11030-015-9628-9. Epub 2015 Sep 2.

Neuroprotective effects of multifaceted hybrid agents targeting MAO, cholinesterase, iron and β-amyloid in ageing and Alzheimer's disease

Weinreb O, Amit T, Bar-Am O, Youdim MB.

Br J Pharmacol. 2016 Jul;173(13):2080-94. doi: 10.1111/bph.13318. Epub 2015 Dec 1.

A Meta-Analysis of C-Reactive Protein in Patients With Alzheimer's Disease

Gong C, Wei D, Wang Y, Ma J, Yuan C, Zhang W, Yu G, Zhao Y.

Am J Alzheimers Dis Other Demen. 2016 May;31(3):194-200. doi: 10.1177/1533317515602087. Epub 2015 Sep 3.

Assessing Fluctuating Cognition in Dementia Diagnosis: Interrater Reliability of the Clinician Assessment of Fluctuation

Van Dyk K, Towns S, Tatarina O, Yeung P, Dorrejo J, Zahodne LB, Stern Y.

Am J Alzheimers Dis Other Demen. 2016 Mar;31(2):137-43. doi: 10.1177/1533317515603359. Epub 2015 Sep 3.

Comparison of motor performance of upper and lower extremities in dual-task tests in patients with mild Alzheimer's dementia

Lin YC, Hsu WC, Wu CK, Chang WH, Wu KP, Wong AM.

Aging Clin Exp Res. 2016 Jun;28(3):491-6. doi: 10.1007/s40520-015-0441-1. Epub 2015 Sep 4.

Magnesium Status in Alzheimer's Disease: A Systematic Review

Veronese N, Zurlo A, Solmi M, Luchini C, Trevisan C, Bano G, Manzato E, Sergi G, Rylander R.

Am J Alzheimers Dis Other Demen. 2016 May;31(3):208-13. doi: 10.1177/1533317515602674. Epub 2015 Sep 7.

Pressure ulcers induced by drug administration: A new concept and report of four cases in elderly patients

Mizokami F, Takahashi Y, Hasegawa K, Hattori H, Nishihara K, Endo H, Furuta K, Isogai Z.

J Dermatol. 2016 Apr;43(4):436-8. doi: 10.1111/1346-8138.13093. Epub 2015 Sep 14.

Cognitive Efficacy (SIB) of 13.3 Versus 4.6 mg/24 h Rivastigmine Patch in Severe Alzheimer's Disease

Isaacson RS, Ferris S, Velting DM, Meng X.

Am J Alzheimers Dis Other Demen. 2016 May;31(3):270-7. doi: 10.1177/1533317515603687. Epub 2015 Sep 14.

Why therapies for Alzheimer's disease do not work: Do we have consensus over the path to follow?

Amtul Z.

Ageing Res Rev. 2016 Jan;25:70-84. doi: 10.1016/j.arr.2015.09.003. Epub 2015 Sep 12.

Alzheimer's disease drug development based on Computer-Aided Drug Design

Zeng H, Wu X.

Eur J Med Chem. 2016 Oct 4;121:851-863. doi: 10.1016/j.ejmech.2015.08.039. Epub 2015 Sep 3.

The Potential Roles of Aquaporin 4 in Alzheimer's Disease

Lan YL, Zhao J, Ma T, Li S.

Mol Neurobiol. 2016 Oct;53(8):5300-9. doi: 10.1007/s12035-015-9446-1. Epub 2015 Oct 3.

Caregiver burden in atypical dementias: comparing frontotemporal dementia, Creutzfeldt-Jakob disease, and Alzheimer's disease

Uflacker A, Edmondson MC, Onyike CU, Appleby BS.

Int Psychogeriatr. 2016 Feb;28(2):269-73. doi: 10.1017/S1041610215001647. Epub 2015 Oct 5.

MicroRNA (miRNA)-Mediated Pathogenetic Signaling in Alzheimer's Disease (AD)

Hill JM, Lukiw WJ.

Neurochem Res. 2016 Feb;41(1-2):96-100. doi: 10.1007/s11064-015-1734-7. Epub 2015 Oct 6.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias